Mao et al., generated CAR-M directed against (FAP, a marker highly expressed by cancer-associated fibroblasts (CAFs)), and demonstrated reduced fibrosis, improved immune infiltration, and delayed tumour progression in colon cancer models (98). This evidence concerns the gene FAP and neoplasm.